Page 1497 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 83 Virus-Associated Lymphoma 1329.e3

89. Barta SK, Lee JY, Kaplan LD, et al: Pooled analysis of AIDS malig- 109. Giordano TP, Henderson L, Landgren O, et al: Risk of non-Hodgkin
nancy consortium trials evaluating rituximab plus CHOP or infusional lymphoma and lymphoproliferative precursor diseases in US veterans
EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. with hepatitis C virus. JAMA 297:2010, 2007.
Cancer 118:3977, 2012. 110. Libra M, Polesel J, Russo AE, et al: Extrahepatic disorders of HCV
90. Levine AM: Management of AIDS-related lymphoma. Curr Opin Oncol infection: a distinct entity of B-cell neoplasia? Int J Oncol 36:1331,
20:522, 2008. 2010.
91. Alwan F, He A, Montoto S, et al: Adding rituximab to CODOX-M/ 111. Amin J, Dore GJ, O’Connell DL, et al: Cancer incidence in people
IVAC chemotherapy in the treatment of HIV-associated Burkitt lym- with hepatitis B or C infection: a large community-based linkage study.
phoma is safe when used with concurrent combination antiretroviral J Hepatol 45:197, 2006.
therapy. AIDS 29:903, 2015. 112. Besson C, Canioni D, Lepage E, et al: Characteristics and outcome of
92. Oriol A, Ribera JM, Bergua J, et al: High-dose chemotherapy and diffuse large B-cell lymphoma in hepatitis C virus-positive patients in
immunotherapy in adult Burkitt lymphoma: comparison of results LNH 93 and LNH 98 Groupe d’Etude des Lymphomes de l’Adulte
in human immunodeficiency virus-infected and noninfected patients. programs. J Clin Oncol 24:953, 2006.
Cancer 113:117, 2008. 113. Chuang SS, Liao YL, Chang ST, et al: Hepatitis C virus infection is
93. Dunleavy K, Pittaluga S, Shovlin M, et al: Low-intensity therapy in significantly associated with malignant lymphoma in Taiwan, particu-
adults with Burkitt’s lymphoma. N Engl J Med 369:1915, 2013. larly with nodal and splenic marginal zone lymphomas. J Clin Pathol
94. Rudek MA, Flexner C, Ambinder RF: Use of antineoplastic agents 63:595, 2010.
in patients with cancer who have HIV/AIDS. Lancet Oncol 12:905, 114. Varma S, Menon MC, Garg A, et al: Hepatitis C virus infection among
2011. patients with non-Hodgkin’s lymphoma in northern India. Hepatol Int
95. Balsalobre P, Diez-Martin JL, Re A, et al: Autologous stem-cell 5:688, 2011.
transplantation in patients with HIV-related lymphoma. J Clin Oncol 115. Omland LH, Jepsen P, Krarup H, et al: Liver cancer and non-Hodgkin
27:2192, 2009. lymphoma in hepatitis C virus-infected patients: results from the
96. Gabarre J, Marcelin AG, Azar N, et al: High-dose therapy plus DANVIR cohort study. Int J Cancer 130:2310, 2012.
autologous hematopoietic stem cell transplantation for human immu- 116. Isikdogan A, Ayyildiz O, Dursun M, et al: Hepatitis C virus in patients
nodeficiency virus (HIV)-related lymphoma: results and impact on with non-Hodgkin’s lymphoma in southeastern Anatolia region of
HIV disease. Haematologica 89:1100, 2004. Turkey: a prospective case-control study of 119 patients. Leuk Lym-
97. Bryant A, Milliken S: Successful reduced-intensity conditioning allo- phoma 44:1745, 2003.
geneic HSCT for HIV-related primary effusion lymphoma. Biol Blood 117. Engels EA, Chatterjee N, Cerhan JR, et al: Hepatitis C virus infection
Marrow Transplant 14:601, 2008. and non-Hodgkin lymphoma: results of the NCI-SEER multi-center
98. Durand CM, Ambinder RF: Hematopoietic stem cell transplantation case-control study. Int J Cancer 111:76, 2004.
in HIV-1-infected individuals: clinical challenges and the potential for 118. Hermine O, Lefrere F, Bronowicki JP, et al: Regression of splenic
viral eradication. Curr Opin Oncol 25:180, 2013. lymphoma with villous lymphocytes after treatment of hepatitis C
99. Hutter G, Zaia JA: Allogeneic haematopoietic stem cell transplantation virus infection. N Engl J Med 347:89, 2002.
in patients with human immunodeficiency virus: the experiences of 119. Kawamura Y, Ikeda K, Arase Y, et al: Viral elimination reduces inci-
more than 25 years. Clin Exp Immunol 163:284, 2011. dence of malignant lymphoma in patients with hepatitis C. Am J Med
100. Gupta V, Tomblyn M, Pedersen TL, et al: Allogeneic hematopoietic 120:1034, 2007.
cell transplantation in human immunodeficiency virus-positive patients 120. Marcucci F, Mele A: Hepatitis viruses and non-Hodgkin lymphoma:
with hematologic disorders: a report from the center for international epidemiology, mechanisms of tumorigenesis, and therapeutic opportu-
blood and marrow transplant research. Biol Blood Marrow Transplant nities. Blood 117:1792, 2011.
15:864, 2009. 121. Geri G, Terrier B, Semoun O, et al: Surrogate markers of B cell
101. Rosen HR: Chronic hepatitis C infection. N Engl J Med 364:2429, non-Hodgkin’s lymphoma in patients with hepatitis C virus-related
2011. cryoglobulinaemia vasculitis. Ann Rheum Dis 69:2177, 2010.
102. Ito M, Kusunoki H, Mochida K, et al: HCV infection and B-cell 122. DeVita S, Sacco C, Sansonno D, et al: Characterization of overt B-cell
lymphomagenesis. Adv Hematol 2011:835314, 2011. lymphomas in patients with hepatitis C virus infection. Blood 90:776,
103. Pawełczyk A, Kubisa N, Jabłońska J, et al: Detection of hepatitis C 1997.
virus (HCV) negative strand RNA and NS3 protein in peripheral blood 123. Paulli M, Arcaini L, Lucioni M, et al: Subcutaneous ‘lipoma-like’
+
+
mononuclear cells (PBMC): CD3 , CD14 and CD19. Virol J 10:346, B-cell lymphoma associated with HCV infection: a new presentation
2013. of primary extranodal marginal zone B-cell lymphoma of MALT. Ann
104. Della Rossa A, Baldini C, Tavoni A, et al: How HCV has changed the Oncol 21:1189, 2010.
approach to mixed cryoglobulinemia. Clin Exp Rheumatol 27(1 Suppl 124. Merli M, Visco C, Spina M, et al: Outcome prediction of diffuse large
52):S115, 2009. B-cell lymphomas associated with hepatitis C virus infection: a study
105. Monti G, Pioltelli P, Saccardo F, et al: Incidence and characteristics of on behalf of the Fondazione Italiana Linfomi. Haematologica 99:489,
non-Hodgkin lymphomas in a multicenter case file of patients with 2014.
hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch 125. Arcaini L, Vallisa D, Rattotti S, et al: Antiviral treatment in patients
Intern Med 165:101, 2005. with indolent B-cell lymphomas associated with HCV infection: a
106. Gisbert JP, Garcia-Buey L, Pajares JM, et al: Prevalence of hepatitis C study of the Fondazione Italiana Linfomi. Ann Oncol 25:1404, 2014.
virus infection in B-cell non-Hodgkin’s lymphoma: systematic review 126. Ennishi D, Maeda Y, Niitsu N, et al: Hepatic toxicity and prognosis in
and meta-analysis. Gastroenterology 125:1723, 2003. hepatitis C virus-infected patients with diffuse large B-cell lymphoma
107. Negri E, Little D, Boiocchi M, et al: B-cell non-Hodgkin’s lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese
and hepatitis C virus infection: a systematic review. Int J Cancer 111:1, multicenter analysis. Blood 116:5119, 2010.
2004. 127. Ennishi D, Terui Y, Yokoyama M, et al: Monitoring serum hepatitis
108. Anderson LA, Engels EA: Hepatitis C virus infection and non-Hodgkin C virus (HCV) RNA in patients with HCV-infected CD20-positive
lymphoma: interesting association or causal relationship? Int J Cancer B-cell lymphoma undergoing rituximab combination chemotherapy.
122(8):x, 2008. Am J Hematol 83:59, 2008.